These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 7232238)

  • 21. [Borderline syndrome: borderline area or no-man's land? On the clinico-psychiatric relevance of borderline diagnoses].
    Sass H; Koehler K
    Nervenarzt; 1983 May; 54(5):221-30. PubMed ID: 6866165
    [No Abstract]   [Full Text] [Related]  

  • 22. Stability and distinctness of borderline personality disorder.
    Barasch A; Frances A; Hurt S; Clarkin J; Cohen S
    Am J Psychiatry; 1985 Dec; 142(12):1484-6. PubMed ID: 4073317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Notes on the potential differentiation of borderline conditions.
    Meissner WW
    Int J Psychoanal Psychother; 1982-1983; 9():3-49. PubMed ID: 6759432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroendocrine evaluation of depression in borderline patients.
    Carroll BJ; Greden JF; Feinberg M; Lohr N; James NM; Steiner M; Haskett RF; Albala AA; DeVigne JP; Tarika J
    Psychiatr Clin North Am; 1981 Apr; 4(1):89-99. PubMed ID: 7232239
    [No Abstract]   [Full Text] [Related]  

  • 25. Treating a young woman with a mix of affective and personality disorders.
    Frances A; Katz SE
    Hosp Community Psychiatry; 1986 Apr; 37(4):331-3. PubMed ID: 3699698
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment outlines for borderline, narcissistic and histrionic personality disorders. The Quality Assurance Project.
    Aust N Z J Psychiatry; 1991 Sep; 25(3):392-403. PubMed ID: 1958163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Posttraumatic personality disorder: a reformulation of complex posttraumatic stress disorder and borderline personality disorder.
    Classen CC; Pain C; Field NP; Woods P
    Psychiatr Clin North Am; 2006 Mar; 29(1):87-112, viii-ix. PubMed ID: 16530588
    [No Abstract]   [Full Text] [Related]  

  • 28. Depression and axis II disorders: comorbidity and relationship to cooperativeness.
    Lott VM; Dunner DL
    Depress Anxiety; 1996-1997; 4(6):268-72. PubMed ID: 9166654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What dimensions underlie cluster B personality disorders?
    Looper KJ; Paris J
    Compr Psychiatry; 2000; 41(6):432-7. PubMed ID: 11086148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depression in borderline adolescents.
    Stone MH
    Am J Psychother; 1981 Jul; 35(3):383-99. PubMed ID: 7294253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Borderline syndrome, neuroses and personality disorders. A comparative study based on research-oriented criteria for borderline schizophrenia].
    Sass H; Koehler K
    Nervenarzt; 1982 Sep; 53(9):519-23. PubMed ID: 7133252
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuroticism and personality disorder in depression.
    Davidson J; Miller R; Strickland R
    J Affect Disord; 1985; 8(2):177-82. PubMed ID: 3157728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Borderline personality and alcohol abuse.
    Vaccani JM
    Arch Psychiatr Nurs; 1989 Apr; 3(2):113-9. PubMed ID: 2653231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phenelzine as a possible treatment for depression in schizophrenic patients.
    Melamed Y; Karniel E; Szor H
    Isr J Psychiatry Relat Sci; 1996; 33(3):211-2. PubMed ID: 9009521
    [No Abstract]   [Full Text] [Related]  

  • 35. Prolonged psychotic states in borderline personality disorder.
    Lotterman AC
    Psychiatr Q; 1985; 57(1):33-46. PubMed ID: 4080867
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Personality disorders in a nonclinical sample of adolescents].
    Chabrol H; Chouicha K; Montovany A; Callahan S; Duconge E; Sztulman H
    Encephale; 2002; 28(6 Pt 1):520-4. PubMed ID: 12506264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bulimia and monoamine oxidase inhibitors: a predictor study.
    Hardy BW; Waller DA; Orsulak PJ
    Tex Med; 1985 Oct; 81(10):39-42. PubMed ID: 3904070
    [No Abstract]   [Full Text] [Related]  

  • 38. Haloperidol vs. phenelzine in continuation therapy of borderline disorder.
    Cornelius JR; Soloff PH; George A; Ulrich RF; Perel JM
    Psychopharmacol Bull; 1993; 29(2):333-7. PubMed ID: 8290683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open trial of MAO inhibitors in bulimia.
    Stewart JW; Walsh BT; Wright L; Roose SP; Glassman AH
    J Clin Psychiatry; 1984 May; 45(5):217-9. PubMed ID: 6373746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ; Sanz-Carrillo C; Ferrández Payo M
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995; 23(4):217-22. PubMed ID: 7484306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.